All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

40

Reset

40 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BMS-986507BL-B01D1, Iza-brenPhase 351 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma

  • AdabelimumabSHR-A2102, SHR2554Phase 320 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Prostate Cancer, Advanced Urothelial Carcinoma

  • 9MW2821Phase 311 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Urothelial Carcinoma, Advanced Urothelial Carcinoma, Locally Advanced or Metastatic Triple-negative Breast Cancer

  • TiragolumabMTIG7192A, RO7092284Phase 311 trials

    Roche (Genentech) · Hepatocellular Carcinoma, Rectal Neoplasms, Rectal Cancer

  • DomvanalimabAB154, GS-0154Phase 310 trials

    Gilead Sciences · Lung Cancer, Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer

  • FavezelimabMK-4280, MK-4820APhase 39 trials

    Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors

  • CetrelimabJNJ-63723283Phase 38 trials

    Johnson & Johnson (Janssen) · Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms

  • BudigalimabABBV-181Phase 36 trials

    AbbVie · Hepatocellular Carcinoma, Non Small Cell Lung Carcinoma, c-MET

  • OlomorasibLY3537982Phase 36 trials

    Eli Lilly · Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis

  • Merck & Co. · Esophageal Squamous Cell Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma

  • SYS6002Phase 35 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Urothelial Carcinoma, Cervical Cancer, Advanced Solid Tumors

  • Cretostimogene GrenadenorepvecCG0070Phase 34 trials

    CG Oncology, Inc. · Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer, Urologic Cancer

  • GimistotugBGB-A445Phase 34 trials

    BeOne Medicines (BeiGene) · Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma

  • LivmoniplimabABBV-151Phase 34 trials

    AbbVie · Hepatocellular Carcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • IO102-IO103Phase 33 trials

    IO Biotech · Metastatic Melanoma, Unresectable Melanoma, Melanoma

  • TARA-002Phase 33 trials

    Protara Therapeutics · Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

  • CMP 001VidutolimodPhase 32 trials

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • Relmada Therapeutics, Inc. · Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Urothelial Carcinoma Bladder

  • SI-B003Phase 210 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • VibostolimabMK-7684Phase 26 trials

    Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma

  • ABSK043Phase 24 trials

    Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer

  • DabogratinibTYRA-300Phase 24 trials

    Tyra Biosciences, Inc · FGFR3 Gene Mutation, FGFR3 Gene Alteration, Achondroplasia

  • INO-9012Phase 24 trials

    Geneos Therapeutics · HCC, Glioblastoma, Urothelial Carcinoma

  • MK-3120SKB410Phase 24 trials

    Merck & Co. · Bladder Cancer, Advanced Solid Tumors, Malignant Neoplasm

  • RO7198457Autogene CevumeranPhase 24 trials

    Roche (Genentech) · Colorectal Cancer Stage II, Colorectal Cancer Stage III, Adenocarcinoma, Pancreatic Ductal

  • AK146D1Phase 23 trials

    Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • ABSK061Phase 22 trials

    Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • BL-M09D1Phase 22 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gynecological Malignancies, Urothelial Carcinoma (UC)

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • INO-5401Phase 22 trials

    Inovio Pharmaceuticals · Glioblastoma, Urothelial Carcinoma

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

  • FF-10832Gemcitabine LiposomePhase 21 trial

    Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer

  • GI-101Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-101APhase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • JB100Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • M6223Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • NKTR-255Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.